N-methylhydroxylamine hydrochloride → HCID 58424550, compound
Reaction equation
Cl.[CH3:2][NH:3][OH:4].C[O-].[Na+].[C:8]([C:10]1[CH:11]=[C:12]([C:16]2[CH:17]=[C:18]3[C:23](=[CH:24][CH:25]=2)[O:22][CH:21]([C:26]2[CH:27]=[N:28][CH:29]=[CH:30][CH:31]=2)[CH2:20]/[C:19]/3=[N:32]\[C:33]#[N:34])[CH:13]=[CH:14][CH:15]=1)#[N:9]>CO>[NH2:34][C:33]1[N:3]([CH3:2])[O:4][C:19]2([C:18]3[C:23](=[CH:24][CH:25]=[C:16]([C:12]4[CH:11]=[C:10]([CH:15]=[CH:14][CH:13]=4)[C:8]#[N:9])[CH:17]=3)[O:22][CH:21]([C:26]3[CH:27]=[N:28][CH:29]=[CH:30][CH:31]=3)[CH2:20]2)[N:32]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of methylhydroxylamine HCl salt (17 mg, 0.2 mmol) in anhydrous MeOH (2 mL) was added NaOMe (25% in MeOH (Wt. %), 0.10 mL, 0.2 mmol), followed by (E)-N-(6-(3-cyanophenyl)-2-(pyridine-3-yl)chroman-4-ylidene)cyanamide (70 mg, 0.2 mmol). After stirring for 10 mins, the solvent was removed in vacuo. The resulting residue was redissolved in DCM (5 mL). The mixture was filtered, and the solvent was removed to give the residue, which was purified by preparative TLC and preparartive HPLC to give 3-(3′-amino-2′-methyl-2-(pyridine-3-yl)-2′H-spiro[chroman-4,5′-[1,2,4]oxadiazole]-6-yl)benzonitrile (2.5 mg, 3%). 1H-NMR (MeOD): 2.40-2.47 (t, 1H), 2.92-3.16 (m, 1H), 3.46 (s, 3H), 5.61-5.69 (m, 1H), 7.21 (m, 1H), 7.64-7.67 (m, 1H), 7.75 (d, 1H), 7.81-7.88 (m, 2H), 7.96-8.00 (t, 1H), 8.04-8.10 (t, 2H), 8.40 (m, 1H), 8.43 (m, 1H), 8.75 (s, 1H).
Workup
- customthe solvent was removed in vacuo
- dissolutionThe resulting residue was redissolved in DCM (5 mL)
- filtrationThe mixture was filtered
- customthe solvent was removed
- customto give the residue, which
- customwas purified by preparative TLC and preparartive HPLC
Sources & evidence
- ORD record
- ord-0260a1349bd04eb1acec797029d013f0
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450308B2
Reaction notes
Loading…